Masimo technologies now available through the nation's top-10 GPOs(1)
IRVINE, Calif., Jan. 21 /PRNewswire-FirstCall/ -- Masimo, the inventor of
Pulse CO-Oximetry and Read-Through Motion and Low Perfusion pulse oximetry,
today announced it has signed a three-year supplier agreement with HealthTrust
Purchasing Group (HealthTrust), representing more than 3,800 facilities,
including acute care hospitals, ambulatory surgery centers, alternate care
sites and physician practices, with an annual purchasing volume of more than
$13 billion. The agreement provides HealthTrust members access to Masimo SET
"gold standard" pulse oximetry and Masimo Rainbow SET monitoring
technologies -- enabling increased patient safety and improved quality of
care.
The addition of HealthTrust expands Masimo's GPO contracts to include all
10 of the nation's top GPOs, allowing hospitals and other care providers
increased access to Masimo SET and Masimo Rainbow SET technologies. This
agreement makes Masimo technologies, bedside and handheld pulse oximetry
monitors and Patient Safety Net available to over 3,800 HealthTrust acute
member facilities nationwide.
More than 100 independent and objective studies demonstrate that Masimo
SET provides the most trustworthy SpO2 and pulse rate measurements even under
the most difficult clinical conditions, including patient motion and low
peripheral perfusion. Masimo Rainbow SET is a breakthrough noninvasive blood
constituent monitoring platform that with a single noninvasive sensor can
measure many blood constituents that previously required invasive procedures.
Masimo Rainbow SET's first application is Pulse CO-Oximetry, the first and
only technology platform capable of continuously and noninvasively measuring
carboxyhemoglobin (SpCOTM) and methemoglobin (SpMetTM) levels in the blood,
pleth variability index (PVI), in addition to oxyhemoglobin (SpO2), perfusion
index (PI) and pulse rate.
Masimo has an unparalleled breadth and depth of pulse oximeter and sensor
solutions as well as its proprietary SatShare interface, which allows a simple
upgrade of an existing monitor to Masimo SET performance. And since Masimo SET
is the leading Read-Through Motion and Low Perfusion SpO2 solution in more
than 100 multiparameter monitors and 50 monitoring brands, hospitals can
easily integrate Masimo technology into any clinical setting, enabling
efficient whole-house conversions.
About HealthTrust
HealthTrust Purchasing Group, headquartered in Brentwood, Tennessee, is a
group purchasing organization that supports over 3,800 not-for-profit and
for-profit facilities including acute care hospitals, ambulatory surgery
centers, physician practices, and alternate care sites. With an annual
purchasing volume by its members of more than $13 billion, HealthTrust is
committed to obtaining the best price for clinically-recommended products,
ensuring their timely delivery and continuously evaluating and improving its
services to the patients, physicians and clinicians it serves. HealthTrust is
located at 155 Franklin Road, Suite 400, Brentwood, TN 37027 Website:
http://www.healthtrustpg.com.
About Masimo
Masimo (Nasdaq: MASI) develops innovative monitoring technologies that
significantly improve patient care-helping solve "unsolvable" problems. In
1995, the company debuted Read-Through Motion and Low Perfusion pulse
oximetry, known as Masimo SET, and with it virtually eliminated false alarms
and increased pulse oximetry's ability to detect life-threatening events. More
than 100 independent and objective studies demonstrate that Masimo SET
provides the most trustworthy SpO2 and pulse rate measurements even under the
most difficult clinical conditions, including patient motion and low
peripheral perfusion. In 2005, Masimo introduced Masimo Rainbow SET, a
breakthrough noninvasive blood constituent monitoring platform that can
measure many blood constituents that previously required invasive procedures.
Rainbow SET continuously and noninvasively measures carboxyhemoglobin (SpCO),
methemoglobin (SpMet), and pleth variability index (PVI), in addition to
oxyhemoglobin (SpO2), perfusion index (PI) and pulse rate, allowing early
detection and treatment of potentially life-threatening conditions. Founded in
1989, Masimo has the mission of "Improving Patient Outcomes and Reducing Cost
of Care by Taking Noninvasive Monitoring to New Sites and Applications."
Additional information about Masimo and its products may be found at
http://www.masimo.com.
Forward Looking Statements
This press release may include forward-looking statements. These forward-
looking statements are based on current expectations about future events
affecting us and are subject to uncertainties and factors, all of which are
difficult to predict and many of which are beyond our control, including:
risks related to our assumption that entering into a multi-year agreement with
HealthTrust will serve to provide substantially increased revenues for the
company, as well as other factors discussed in the "Risk Factors" section of
our quarterly report on Form 10-Q for the quarter ended September 29, 2007,
filed with the Securities and Exchange Commission on November 1, 2007.
Although we believe that the expectations reflected in our forward-looking
statements are reasonable, we do not know whether our expectations will prove
correct. You are cautioned not to place undue reliance on these forward-
looking statements, which speak only as of the date hereof. We do not
undertake any obligation to update, amend or clarify these forward-looking
statements or the risk factors contained in our quarterly report on Form 10-Q
for the quarter ended September 29, 2007, whether as a result of new
information, future events or otherwise, except as may be required under the
federal securities laws.
(1) Healthcare Purchasing News research, May 2006
(http://www.hpnonline.com/resources/GPOs.html)
Contact: Tom McCall
Masimo Corporation
949-297-7075
Masimo, SET, Signal Extraction Technology, Improving Outcomes and Reducing
Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications,
Patient SafetyNet, Rainbow, SpCO, SpMet, PVI and Pulse CO-Oximeter are
trademarks or registered trademarks of Masimo Corporation.
SOURCE Masimo Corporation